GlycoMimetics, Inc. (NASDAQ:GLYC – Get Rating) passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $1.88 and traded as low as $1.25. GlycoMimetics shares last traded at $1.33, with a volume of 96,727 shares changing hands. Wall Street Analysts Forecast Growth A number of research […]
GlycoMimetics, Inc. (NASDAQ:GLYC – Get Rating) – Equities researchers at Jefferies Financial Group issued their Q1 2023 earnings per share estimates for GlycoMimetics in a note issued to investors on Wednesday, March 29th. Jefferies Financial Group analyst R. Song anticipates that the biotechnology company will earn ($0.17) per share for the quarter. The consensus estimate […]
GlycoMimetics (NASDAQ:GLYC – Get Rating)‘s stock had its “buy” rating restated by HC Wainwright in a research report issued to clients and investors on Thursday, Benzinga reports. They currently have a $8.00 target price on the biotechnology company’s stock. Separately, StockNews.com lowered GlycoMimetics from a “hold” rating to a “sell” rating in a report on […]
AE Wealth Management LLC purchased a new position in shares of GlycoMimetics, Inc. (NASDAQ:GLYC – Get Rating) during the fourth quarter, HoldingsChannel.com reports. The institutional investor purchased 26,898 shares of the biotechnology company’s stock, valued at approximately $82,000. Other hedge funds and other institutional investors have also recently made changes to their positions in the […]
StockNews.com initiated coverage on shares of GlycoMimetics (NASDAQ:GLYC – Get Rating) in a research report issued on Friday. The brokerage set a “hold” rating on the biotechnology company’s stock. Separately, Zacks Investment Research upgraded GlycoMimetics from a “hold” rating to a “buy” rating and set a $0.75 price target on the stock in a research […]